GlassScriptPhysician profile
William D Armstrong
NPI 1770564411
$941.98
in general payments reported to CMS, 2019-2025
9 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $229 · 2023: $227 · 2024: $62.34 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $396.02 | 2021-2024 | Covera, Fluency Endovascular Stent Graft, Lutonix Drug Coated Balloon |
| Medtronic, INC. | $194.01 | 2021-2023 | Chameleon |
| Boston Scientific Corporation | $149.99 | 2025 | Lithovue |
| Mozarc Medical US LLC | $108.45 | 2023-2025 | Chameleon |
| Radius Health, INC. | $25.60 | 2021 | |
| Argon Medical Devices, INC. | $19.36 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.96 | 2024 | Lifevest |
| Stemline Therapeutics INC. | $16.58 | 2023 | Orserdu |
| Terumo Medical Corporation | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.